deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT03102437

Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System (FIX-HF-5CA)

FIX-HF-5CA: Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%

Sponsor: Impulse Dynamics

Updated 20 times since 2017 Last updated: Nov 21, 2021 Started: Jul 1, 2017 Primary completion: Dec 16, 2019 Completion: Dec 16, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The primary objective of the protocol was to allow ongoing access to treatment of patients suffering from moderate to severe heart failure at selected investigational sites until the PMA was approved by the FDA for the OPTIMIZER System.

Listed as NCT03102437, this NA trial focuses on CHF and Chronic Heart Disease and remains terminated or withdrawn. Sponsored by Impulse Dynamics, it has been updated 20 times since 2017, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Study Description(click to expand)

The Continued Access study is a prospective, non-randomized, multi-center study designed to allow controlled access to the Optimizer Smart System until the PMA order has been issued by the FDA.

The Continued Access study is a prospective, non-randomized, multi-center study designed to allow controlled access to the Optimizer Smart System until the PMA order has been issued by the FDA.

Status Flow

~May 2017 – ~Aug 2017 · 3 months · monthly snapshot~Aug 2017 – ~Oct 2017 · 2 months · monthly snapshot~Oct 2017 – ~Dec 2017 · 2 months · monthly snapshot~Dec 2017 – ~Jan 2018 · 31 days · monthly snapshot~Jan 2018 – ~May 2018 · 4 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshot~Sep 2018 – ~Feb 2019 · 5 months · monthly snapshot~Feb 2019 – ~May 2019 · 3 months · monthly snapshot~May 2019 – ~Jul 2019 · 2 months · monthly snapshot~Jul 2019 – ~Feb 2020 · 7 months · monthly snapshot~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 19 months · monthly snapshot~Jan 2026 – present · 3 months · monthly snapshot

Change History

20 versions recorded
  1. Jan 2026 — Present [monthly]

    Terminated NA

  2. Sep 2024 — Present [monthly]

    Terminated NA

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  4. Jan 2023 — Jul 2024 [monthly]

    Terminated NA

  5. Dec 2022 — Jan 2023 [monthly]

    Terminated NA

Show 15 earlier versions
  1. Dec 2021 — Dec 2022 [monthly]

    Terminated NA

    Status: CompletedTerminated

  2. Jan 2021 — Dec 2021 [monthly]

    Completed NA

  3. Feb 2020 — Jan 2021 [monthly]

    Completed NA

    Status: RecruitingCompleted

  4. Jul 2019 — Feb 2020 [monthly]

    Recruiting NA

  5. May 2019 — Jul 2019 [monthly]

    Recruiting NA

  6. Feb 2019 — May 2019 [monthly]

    Recruiting NA

  7. Sep 2018 — Feb 2019 [monthly]

    Recruiting NA

  8. Jul 2018 — Sep 2018 [monthly]

    Recruiting NA

  9. Jun 2018 — Jul 2018 [monthly]

    Recruiting NA

  10. May 2018 — Jun 2018 [monthly]

    Recruiting NA

  11. Jan 2018 — May 2018 [monthly]

    Recruiting NA

  12. Dec 2017 — Jan 2018 [monthly]

    Recruiting NA

  13. Oct 2017 — Dec 2017 [monthly]

    Recruiting NA

  14. Aug 2017 — Oct 2017 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  15. May 2017 — Aug 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Impulse Dynamics
Data source: Impulse Dynamics

For direct contact, visit the study record on ClinicalTrials.gov .